跳至主要内容
临床试验/IRCT20150304021338N3
IRCT20150304021338N3招募中3 期

Comparative study of the effect of topical vitamin K with placebo in the treatment of skin rash in patients with metastatic colon cancer treated with Cetuximab

Esfahan University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with metastatic colorectal cancer that are candidates for treatment with Cetuximab .
  • Patients with grade 1 to 4 skin lesions, after using Cetuximab(based on Common Terminology Criteria for Adverse Events4 (CTCAE4))
  • Be over 18 years old
  • The patient should not undergo radiotherapy.
  • Have a desire to participate in the study.

排除标准

  • The patient has skin lesions before receiving cetuximab (including rash, acne, pustules, inflammatory erythema)
  • Being pregnant or in breastfeeding duration
  • Previous history of allergies to compounds containing vitamin K
  • Has a psychiatric disorder that is not able to participate in the study
  • For other reasons, he is taking drugs that have a drug interaction with topical vitamin K
  • Be taking medicinal compounds containing vitamin K

研究者

相似试验